GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (FRA:WF6) » Definitions » Marketable Securities

MindBio Therapeutics (FRA:WF6) Marketable Securities : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. MindBio Therapeutics's Marketable Securities for the quarter that ended in Dec. 2024 was €0.00 Mil.

MindBio Therapeutics's annual Marketable Securities declined from Jun. 2022 (€0.02 Mil) to Jun. 2023 (€0.01 Mil) and declined from Jun. 2023 (€0.01 Mil) to Jun. 2024 (€0.00 Mil).


MindBio Therapeutics Marketable Securities Historical Data

The historical data trend for MindBio Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Marketable Securities Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Marketable Securities
- 0.02 0.01 -

MindBio Therapeutics Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - - -

MindBio Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


MindBio Therapeutics  (FRA:WF6) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


MindBio Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


MindBio Therapeutics Business Description

Traded in Other Exchanges
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.

MindBio Therapeutics Headlines

No Headlines